{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:10:08Z","timestamp":1793653808620,"version":"4.5.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012132","name":"Maritime Safety Administration, Ministry of Transport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jid.2025.11.016","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:54:52Z","timestamp":1765421692000},"page":"1867-1875.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-2651","authenticated-orcid":false,"given":"Amit G.","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-5463","authenticated-orcid":false,"given":"Charles W.","family":"Lynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4217-1356","authenticated-orcid":false,"given":"Maryam","family":"Shayesteh Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8342-0793","authenticated-orcid":false,"given":"Ira H.","family":"Thorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1539-8397","authenticated-orcid":false,"given":"Katherine","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-9249","authenticated-orcid":false,"given":"Lawrence J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-3241","authenticated-orcid":false,"given":"Babak","family":"Soltanalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5021-9412","authenticated-orcid":false,"given":"Diana","family":"Stefani-Hunyady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6286-2069","authenticated-orcid":false,"given":"Deanna","family":"Kornacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1294-3770","authenticated-orcid":false,"given":"Mark S.","family":"Amster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.11.016_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2017.0002","article-title":"Phototherapy for vitiligo: a systematic review and meta-analysis","volume":"153","author":"Bae","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.11.016_bib3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/jdv.18257","article-title":"Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA","volume":"36","author":"Bibeau","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.11.016_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjd.17013","article-title":"International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation","volume":"180","author":"Eleftheriadou","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjd.13839","article-title":"Living with vitiligo: results from a national survey indicate differences between skin phototypes","volume":"173","author":"Ezzedine","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the vitiligo Area Scoring Index","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.404","article-title":"Safety and efficacy of Ruxolitinib cream for the treatment of vitiligo: a randomised controlled trial secondary analysis at 3 years","volume":"4","author":"Harris","year":"2024","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jid.2025.11.016_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s13555-022-00752-8","article-title":"Meaningful changes in what matters to individuals with vitiligo: content validity and meaningful change thresholds of the Vitiligo Area Scoring Index (VASI)","volume":"12","author":"Kitchen","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.11.016_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","article-title":"Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure","volume":"77","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/jdpa.0000000000000041","article-title":"Understanding the mechanism of disease of vitiligo and the impact on clinical management","volume":"19","author":"McElroy","year":"2025","journal-title":"J Dermatol Physician Assist"},{"key":"10.1016\/j.jid.2025.11.016_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00403-017-1792-6","article-title":"Expression of Janus kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study","volume":"310","author":"Nada","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.11.016_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/12034754231223699","article-title":"Real-world experience of vitiligo patients: a retrospective chart review","volume":"28","author":"Obeng-Asumeng","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.11.016_bib13","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s13555-024-01241-w","article-title":"Assessing participants' experiences with vitiligo from patient interviews","volume":"14","author":"Pandya","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.11.016_bib14","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.jid.2022.05.1093","article-title":"Addition of narrow-band UVB phototherapy to Ruxolitinib cream in patients with vitiligo","volume":"142","author":"Pandya","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib15","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quint\u00e1s-Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jid.2025.11.016_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.11.016_bib18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.11.016_bib19","series-title":"Facial and total Vitiligo Area Scoring Index response shift during 104 weeks of ruxolitinib cream treatment for vitiligo: results from the open-label arm of the TRuE-V long-term extension phase 3 study","author":"Rosmarin","year":"2023"},{"key":"10.1016\/j.jid.2025.11.016_bib20","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/jdv.19450","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force-part 2: Specific treatment recommendations","volume":"37","author":"Seneschal","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.11.016_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.19592","article-title":"Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light vitiligo Trial","volume":"184","author":"Thomas","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.11.016_bib22","series-title":"Efficacy of prolonged Ruxolitinib cream treatment for vitiligo among patients with limited or no initial response at 6 months","author":"Wolkerstorfer","year":"2023"},{"key":"10.1016\/j.jid.2025.11.016_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.det.2019.08.005","article-title":"Phototherapy for vitiligo","volume":"38","author":"Zubair","year":"2020","journal-title":"Dermatol Clin"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25036243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25036243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:13:42Z","timestamp":1782486822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25036243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022202X25036243"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.11.016","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}